Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice is a research paper published in Antimicrobial Agents and Chemotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: R01 AI131424
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: R01 AI161348
Bill and Melinda Gates Foundation
Grant: INV-049940
Burroughs Wellcome Fund
Grant: Career Award for Medical Scientists
National Institutes of Health
Grant: 5R01AI161348-02
Revising Anti-coronavirus Compounds to Enhance Activity and Optimize Delivery
National Institutes of Health
Grant: 5R01AI131424-04
Development of Sustained-Release Anti-HIV Nucleoside Phosphonate Nanoparticles
UC | UCSD | Center for AIDS Research, University of California, San Diego
UC | UCSD | Center for AIDS Research, University of California, San Diego (CFAR)
UC | UCSD | Center for AIDS Research, University of California, San Diego (CFAR)
FWCI
1.75
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals